Poly Medicure Complete Financial Statements
POLYMED • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Poly Medicure (POLYMED).
Downloads include all available records across all periods.
For market performance, see the
POLYMED stock price today
.
Profitability Ratios
Net Profit Margin
19.21%
2025 data
EBITDA Margin
31.32%
2025 data
Operating Margin
26.00%
2025 data
Return on Assets
2.88%
2025 data
Return on Equity
3.33%
2025 data
Balance Sheet Ratios
Current Ratio
33.63
2025 data
Debt to Equity
1.15
2025 data
Equity Ratio
86.63%
2025 data
Asset Turnover
0.15
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+7.2%
Year-over-Year
Net Profit Growth
+5.7%
Year-over-Year
EBITDA Growth
+5.6%
Year-over-Year
Expense Growth
+7.9%
Year-over-Year
Assets Growth
+71.8%
Year-over-Year
Equity Growth
+88.2%
Year-over-Year
Liabilities Growth
+71.8%
Year-over-Year
Operating Cash Flow Growth
-9.8%
Year-over-Year
Investing Cash Flow Growth
-395.4%
Year-over-Year
Financing Cash Flow Growth
+4855.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 479 | 467 | 447 | 447 | 393 | 402 | 448 | 352 | 316 | 335 | 357 | 284 | 266 | 254 | 300 | 237 | 221 | 223 | 238 | 203 | 178 | 175 | 209 | 179 | 180 | 166 | 185 | 155 | 137 | 159 |
| Expenses | 329 | 321 | 298 | 305 | 282 | 281 | 310 | 253 | 224 | 234 | 249 | 210 | 202 | 202 | 214 | 173 | 159 | 157 | 179 | 143 | 131 | 125 | 146 | 132 | 139 | 125 | 135 | 116 | 103 | 125 |
| EBITDA | 150 | 146 | 149 | 142 | 112 | 121 | 138 | 99 | 92 | 101 | 108 | 74 | 64 | 51 | 86 | 64 | 63 | 66 | 59 | 60 | 47 | 50 | 63 | 47 | 41 | 41 | 50 | 39 | 35 | 35 |
| Operating Profit Margin % | 26.00% | 27.00% | 26.00% | 27.00% | 26.00% | 27.00% | 27.00% | 25.00% | 27.00% | 27.00% | 27.00% | 24.00% | 22.00% | 19.00% | 25.00% | 23.00% | 25.00% | 26.00% | 22.00% | 28.00% | 23.00% | 27.00% | 28.00% | 24.00% | 20.00% | 23.00% | 25.00% | 23.00% | 23.00% | 20.00% |
| Depreciation | 25 | 21 | 23 | 21 | 16 | 20 | 22 | 16 | 15 | 16 | 16 | 14 | 14 | 14 | 14 | 14 | 13 | 13 | 14 | 11 | 10 | 11 | 13 | 10 | 10 | 10 | 11 | 9 | 9 | 10 |
| Interest | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 4 | 0 | 2 | 1 | 5 | 0 | -2 | 3 | -1 | 3 | 8 | 3 | 5 | 2 | 2 | 3 | 5 | 7 | 4 | -1 |
| Profit Before Tax | 122 | 123 | 123 | 118 | 93 | 99 | 113 | 81 | 75 | 83 | 88 | 59 | 49 | 36 | 67 | 50 | 52 | 50 | 46 | 46 | 29 | 36 | 46 | 36 | 30 | 28 | 34 | 23 | 22 | 26 |
| Tax | 30 | 31 | 30 | 31 | 24 | 24 | 28 | 19 | 16 | 20 | 23 | 16 | 13 | 9 | 17 | 12 | 13 | 13 | 11 | 11 | 6 | 10 | 11 | 7 | 8 | 8 | 9 | 9 | 9 | 10 |
| Net Profit | 92 | 92 | 93 | 87 | 68 | 74 | 85 | 62 | 59 | 63 | 65 | 44 | 36 | 27 | 50 | 38 | 39 | 38 | 35 | 35 | 23 | 27 | 35 | 28 | 22 | 20 | 25 | 15 | 13 | 16 |
| Earnings Per Share (₹) | 9.06 | 8.92 | 9.19 | 9.01 | 7.12 | 7.71 | 8.48 | 6.48 | 6.13 | 6.54 | 6.78 | 4.53 | 3.77 | 2.81 | 5.21 | 3.99 | 4.26 | 3.92 | 3.60 | 3.97 | 2.57 | 3.03 | 4.00 | 3.22 | 2.44 | 2.24 | 2.83 | 1.65 | 1.50 | 1.82 |
Related Pages for Poly Medicure
Additional stock information and data for POLYMED
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 3,193 | 1,859 | 1,577 | 1,377 | 1,224 | 767 | 654 | 565 | 457 | 387 | 364 |
| Current Assets | 1,917 | 842 | 807 | 783 | 704 | 318 | 302 | 255 | 205 | 171 | 160 |
| Fixed Assets | 1,084 | 867 | 635 | 488 | 426 | 363 | 306 | 265 | 207 | 182 | 166 |
| Capital Work in Progress | 101 | 76 | 78 | 43 | 21 | 25 | 19 | 18 | 20 | 14 | 10 |
| Investments | 1,077 | 167 | 126 | 346 | 354 | 25 | 8 | 17 | 3 | 0 | 0 |
| Other Assets | 930 | 749 | 738 | 499 | 422 | 354 | 321 | 264 | 227 | 191 | 189 |
| LIABILITIES | |||||||||||
| Total Liabilities | 3,193 | 1,859 | 1,577 | 1,377 | 1,224 | 767 | 654 | 565 | 457 | 387 | 364 |
| Current Liabilities | 57 | 37 | 42 | 63 | 87 | 135 | 119 | 104 | 72 | 50 | 55 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 2,766 | 1,470 | 1,242 | 1,088 | 966 | 435 | 381 | 338 | 272 | 229 | 196 |
| Share Capital | 51 | 48 | 48 | 48 | 48 | 44 | 44 | 44 | 44 | 22 | 22 |
| Reserves & Surplus | 2,715 | 1,422 | 1,194 | 1,040 | 918 | 391 | 337 | 294 | 227 | 207 | 174 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 240 | 266 | 191 | 124 | 119 | 131 | 107 | 75 | 56 | 63 | 63 |
| Investing Activities | -1,194 | -241 | -179 | -85 | -436 | -110 | -101 | -88 | -56 | -31 | -59 |
| Financing Activities | 951 | -20 | -13 | -35 | 317 | -21 | -5 | 16 | 0 | -31 | -6 |
| Net Cash Flow | -3 | 5 | -1 | 3 | 0 | 1 | 1 | 3 | 0 | 1 | -2 |